Cargando…
Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia
Mutations in the genetic sequence of the DNA de novo methyltransferase DNMT3A (DNA methyltransferase 3A) are found in many patients with acute myeloid leukemia (AML). They lead to dysfunction of DNMT3A protein and represent a marker for poor prognosis. Effects of genetic mutations can be mimicked by...
Autores principales: | Jost, E, Lin, Q, Weidner, C I, Wilop, S, Hoffmann, M, Walenda, T, Schemionek, M, Herrmann, O, Zenke, M, Brümmendorf, T H, Koschmieder, S, Wagner, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051212/ https://www.ncbi.nlm.nih.gov/pubmed/24280869 http://dx.doi.org/10.1038/leu.2013.362 |
Ejemplares similares
-
DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia
por: Božić, Tanja, et al.
Publicado: (2015) -
Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia
por: Oing, Christoph, et al.
Publicado: (2011) -
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
por: Herrmann, Oliver, et al.
Publicado: (2019) -
DNMT3L enables accumulation and inheritance of epimutations in transgenic Drosophila
por: Basu, Amitava, et al.
Publicado: (2016) -
Characteristics of DNMT3A mutations in acute myeloid leukemia
por: Park, Dong Jin, et al.
Publicado: (2020)